Bioequivalence and Analytical Validation of Tizanidine in Human Plasma Using LC-MS/MS
کلمات کلیدی:
Tizanidine hydrochloride , LC-MS/MS , Bioequivalence , Analytical method validation, Pharmacokinetics , Liquid-liquid extractionچکیده
This study presents a detailed bioequivalence analysis and method validation for quantifying tizanidine hydrochloride (TIZ) in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS/MS). The analytical method incorporates internal standardization with amlodipine besylate, achieving high sensitivity and specificity through multiple reaction monitoring (MRM). A robust linear calibration curve (50–3200 ppt) was established, weighted by 1/x, with a correlation coefficient exceeding 0.99. Analytical method validation adhered to ICH M10 guidelines, ensuring accuracy, precision, specificity, and robustness. The liquid-liquid extraction protocol optimized sample preparation, while system suitability was confirmed through key performance parameters, including retention time stability and signal-to-noise ratios.
Bioequivalence was evaluated in a single-dose crossover study with healthy volunteers, comparing test and reference formulations. Pharmacokinetic parameters such as maximum plasma concentration (Cmax), time to reach Cmax (Tmax), and area under the curve (AUC) were statistically analyzed, meeting regulatory acceptance criteria. The methodology demonstrated negligible matrix effects and interference, enabling precise quantification of TIZ at therapeutic concentrations. These findings confirm the reliability of this validated LC-MS/MS method for bioequivalence studies and therapeutic drug monitoring of tizanidine.
دانلودها
مراجع
1. Bhadauria, R., and Joshi, A. (2019). Bioanalytical method development and validation for estimation of tizanidine in human plasma using LC-MS/MS. Journal of Pharmaceutical Analysis. 9(4), 253–260.
2. Chandra, R., and Kumar, M. (2014). Advances in pharmacokinetics: Applications in bioequivalence studies. International Journal of Drug Development and Research. 6(3), 11–25.
3. International Council for Harmonisation. (2019). ICH M10: Guideline for Bioanalytical Method Validation. ICH Official Publication. Retrieved from [ICH Website].
4. Nirogi, R., Kandikere, V., Shukla, M., Mudigonda, K., Maurya, S., and Boosi, R. (2006). Liquid chromatography–tandem mass spectrometry method for quantification of tizanidine in human plasma. Biomedical Chromatography. 20(9), 903–911.
5. Singh, A., and Chauhan, R. (2020). Recent advances in bioanalytical method validation: A regulatory perspective. Journal of Pharmaceutical Sciences. 109(1), 5–16.
6. Villaverde, J., and Sánchez, C. (2021). Modern approaches in LC-MS/MS for quantification of small molecules in biological matrices. Analytical Chemistry Research. 30, 10038.
7. Waters, P., and Griffith, L. (2020). Application of high-performance liquid chromatography in pharmaceutical analysis: A decade of advancements. Journal of Chromatographic Science. 58(7), 453–468.
